DUBLIN, Calif., Oct. 28 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that it will release its 2008 third quarter financial results on Tuesday, November 4, 2008. SuperGen's management team will provide details of the Company's financial results and any revised outlook for the future.
A press release will be transmitted to the news media immediately following the close of the market on November 4th. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast will be accessible via the Investor Relations section of the Company's Web site at http://www.supergen.com. A webcast replay of the live conference call will be available shortly following the event. Alternatively, you may access a replay of the conference call by dialing 1-888-286-8010 (domestic) and 1-617-801-6888 (international); replay passcode number is 37633541. The webcast replay and conference call replay will be available for 90 days.
Based in Dublin, Calif., SuperGen Inc. is a pharmaceutical company
dedicated to the discovery and development of novel cancer therapies.
SuperGen is developing a number of therapeutic anticancer products focused
on kinase and cell signaling inhibitors and DNA methyltransferase
inhibitors. For more information about SuperGen, please visit
Timothy L. Enns
SVP, Corporate Communications & Business Development
Tel: (925) 560-0100
Mary M. Vegh
Manager, Investor Relations
Tel: (925) 560-2845
Dorland Global Public Relations
Michael Beckerich (Media)
Tel: (212) 677-7632
|SOURCE SuperGen Inc.|
Copyright©2008 PR Newswire.
All rights reserved